These effects, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the idea of concentrating on ACKR3 as a singular way to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. Observe: Results could change about https://margaretu738lbs3.jts-blog.com/profile